GL1X · GenesisL1 explorer

MolNFT v1 · #50472 · protein

B-specific alpha-1,3-galactosyltransferase G176R S235G mutant (aabb) + udpgal + deoxy-acceptor

2RJ7 · Glycoprotein-fucosylgalactoside alpha- galactosyltransferase: “B-specific alpha-1,3-galactosyltransferase G176R S235G mutant (aabb) + udpgal + deoxy-acceptor”. X-ray diffraction, 3 ligands (GDU, DA8, MN), 2 pockets (best…

PDB
2RJ7
Type
protein
Length
292 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycoprotein-fucosylgalactoside alpha- galactosyltransferase
EC
2.4.1.37
UniProt
P16442
Ligands
GDU, DA8, MN
Pockets
2 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycoprotein-fucosylgalactoside alpha- galactosyltransferase (EC 2.4.1.37)protein29232% helix, 19% strandP16442

Ligands and binding sites

  • GDU · Galactose-uridine-5'-diphosphate · ligand · chains A
  • DA8 · octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside · ligand · chains A
  • MN · Manganese (II) ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14420.750.8445GDU, MN, DA8
2710.470.8314empty

Compared structures

  • 2RJ7 · B-specific alpha-1,3-galactosyltransferase G176R S235G mutant (AABB) + UDPGal +… · the same entry in another collection · chain A against A, TM-score 1.00
  • P16442 · AlphaFold monomer V2.0 prediction for histo-blood group abo system transferase (P16442) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.